Primary cultured fibroblasts derived from patients with chronic wounds: a methodology to produce human cell lines and test putative growth factor therapy such as GMCSF

BACKGROUND: Multiple physiologic impairments are responsible for chronic wounds. A cell line grown which retains its phenotype from patient wounds would provide means of testing new therapies. Clinical information on patients from whom cells were grown can provide insights into mechanisms of specifi...

Descripción completa

Detalles Bibliográficos
Autores principales: Brem, Harold, Golinko, Michael S, Stojadinovic, Olivera, Kodra, Arber, Diegelmann, Robert F, Vukelic, Sasa, Entero, Hyacinth, Coppock, Donald L, Tomic-Canic, Marjana
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Methodology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2621139/
https://www.ncbi.nlm.nih.gov/pubmed/19046453
http://dx.doi.org/10.1186/1479-5876-6-75

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2621139/
https://www.ncbi.nlm.nih.gov/pubmed/19046453
http://dx.doi.org/10.1186/1479-5876-6-75

Ejemplares similares